Member Info for Laura2022

0.49p paid

Not much available

Total re rate to come during 2026

And a USA fund too

Moving nicely into the 1.4s

Looks very good here and the share price has completely been floored from 60p , largely due to global events and of course the placing

I have.made a SIPP investment today

Armchair/86

I've got over 200 on Lse.in the green bin

They're either

Bitter

Unhinged

Lonely

Hello 86kb

And with 4 people.on filter ( imagine still posting year on year on a share you dont like ) its very smooth

Breaking out pf that wedge i mentioned at 4.8p :)

Richard

How do you know please ?

Thought meeting wasn't till later BST ?

Nice day

40p to 0.6p in 5yrs due to no fault dispute

Plexus is well-placed to accelerate the commercialisation of its remaining POS-GRIP applications, while continuing to expand its presence in higher-margin subsea and production markets. This approach is intended to unlock substantial additional value from the Group's proprietary technology in the higher-margin subsea and production markets.

Pavan Bakhshi, Managing Director of MPL, commented:

"We continue to be proud of the support we received from international investors to fund MPL on the London Stock Exchange and to build key infrastructure in India.

We have presented a comprehensive and credible proposal to fully redeem the debt and repay all outstanding financial creditors. It is difficult to understand why the proposal has not been considered and implemented in a timely manner. We will continue to fight to retain our asset, restore it to operational success and protect stakeholders' interests. Anything other than this would be a travesty.

Major shareholders: Mercantile Ports & Logistics Limited

Name Equities % Valuation

Karanpal Singh

27.75 %

Armstrong Investments Ltd. (Isle of Man)

3.65 %

Oberon Investments Ltd. (GB Investment Management)

2.14 %

Jeremy Warner-Allen

0.7763 %

Jay Mehta

0.7015 %

John Fitzgerald

0.2563 %

Dmitri Tsvetkov

0.1844 %

Thanks for that F1 driver

Into the final 30 minutes it became more difficult to buy in size ( maximum at 0.49p was about £7000)

Interesting few days /weeks ahead with stock accumulation

Important thing I took from the presentation was :

>the underlying business being at an "inflection point ",

>continued engagement with new DoseMeRx mgmt

>NHS trail recruitment finished last month and already have enough data to be making progress on the.results

> 14 project current pipeline which IF ALL converted would add £1.4mln

Important bit of deal

The structure of the Lanstead subscription provides a mechanism through which the Company may potentially benefit from future share price performance, with the 8p Benchmark Price acting as the reference point for returns under the Sharing Arrangemen

Exactly crazy year

Its really not that difficult

The new TR1 exactly matches the TVR as shown in RNS of a few days ago

112,236,910 shares

Its quite simple

It's to reflect the closing of the placement which officially happened on the 8th

Allotment of Shares

 

At a Board meeting held following the General Meeting, 100,000,000 Subscription Shares, 12,000,000 Value Payment Shares, 7,812,447 WRAP Retail Offer Shares and 1,375,000 Fee Shares (together the "New Ordinary Shares") have been allotted.

 

Application has been made for the New Ordinary Shares to be admitted to trading on AIM ("Admission"), and Admission is expected to occur at 8.00 a.m. on 8 April 2026.

Or

.even better...as a "genuine" investor submit a question about DoseMeRx BEFORE the meeting

But that lf course would be too much to ask as a non - holder for 2yrs :)